Zachary Sher is a business law associate with Foley & Lardner LLP. He is based in the Boston office where he is a member of the Health Care Practice Group.
Prior to joining Foley, Zachary served as an associate for a New York law firm where he focused on transactional health care and employment law. He provided guidance regarding acquisitions, real estate, employment issues, and state and federal regulatory health care laws to various healthcare clients.
Representative Experience
- Represented Sports Medicine North Orthopedic Surgery, Inc., and its affiliated ambulatory surgery center in their acquisition by Connecticut-based orthopedic and spine care management services organization Spire Orthopedic Partners, a portfolio company of Kohlberg & Co.
- Represented Accentcare, Inc., a leading provider of home health services, in connection with a joint venture with GeissMed, a regional primary care provider platform.
Foley Advises CopilotIQ in Strategic Merger with Biofourmis
Foley & Lardner LLP advised CopilotIQ, a health care technology company focused on improving the lives of older adults with chronic conditions, in its strategic merger with Biofourmis, a global technology-enabled care delivery company, delivering in-home care solutions serving enterprise health care customers.
Foley Represents Saint Luke’s in Merger with BJC Health System
Foley & Lardner LLP represented Saint Luke’s Health System of Kansas City in its transaction with BJC Health System of St. Louis , officially combining as a single integrated, academic, patient-centric Missouri-based health system.
Foley Attorneys Publish Article on New York OMIG Compliance Program Enforcement
Foley & Lardner LLP partners Jeffrey Thrope, Lawrence Vernaglia, and associate Zachary Sher authored the Compliance Today article, “NY OMIG compliance program enforcements begins, self-disclosure requirements expand.”
DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information
In June 2023, the U.S. Food and Drug Administration published final guidance on presenting risk and efficacy information for direct-to-consumer promotional labeling and advertisements for prescription drug and biologic products for humans and drug products for animals.
Foley Represents Transcarent in Acquiring Part of 98point6 for $100M
Foley & Lardner LLP represented health and care experience company Transcarent in acquiring AI-powered virtual care platform capabilities and the care business of 98point6 in a deal worth up to $100 million.
Foley Represents PetMed Express in Partnership with Vetster
Foley & Lardner LLP represented PetMed Express, Inc. (NASDAQ: PETS), an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements, in its partnership with Vetster, a leading veterinary telemedicine and pet-care marketplace.